Literature DB >> 15732973

Blue luminescent 2-(2'-pyridyl)benzimidazole derivative ligands and their orange luminescent mononuclear and polynuclear organoplatinum(II) complexes.

Qin-De Liu1, Wen-Li Jia, Suning Wang.   

Abstract

Five new 2-(2'-pyridyl)benzimidazole derivative ligands, 1,4-bis[2-(2'-pyridyl)benzimidazolyl]benzene (1,4-bmb), 4,4'-bis[2-(2'-pyridyl)benzimidazolyl]biphenyl (bmbp), 1-bromo-4-[2-(2'-pyridyl)benzimidazolyl]benzene (Brmb), 1,3-bis[2-(2'-pyridyl)benzimidazolyl]benzene (1,3-bmb), and 1,3,5-tris[2-(2'-pyridyl)benzimidazolyl]benzene (tmb), have been synthesized by Ullmann condensation methods. The corresponding mononuclear and polynuclear PtII complexes, Pt2(1,4-bmb)Ph4 (1), Pt2(bmbp)Ph4 (2), Pt(Brmb)Ph2 (3), Pt2(1,3-bmb)Ph4 (4), and Pt3(tmb)Ph6 (5), have been obtained by the reaction of the appropriate ligand with [PtPh2(SMe2)]n. The structures of the free ligands 1,4-bmb, bmbp, and tmb, as well as the complexes 1-3, were determined by single-crystal X-ray diffraction. All ligands display fluorescent emissions in the purple/blue region of the spectrum at ambient temperature and phosphorescent emissions in the blue/green region at 77 K, which are attributable to ligand-centered pi --> pi* transition. No ligand-based emission was observed for the PtII complexes 1-5. All PtII complexes display orange/red emissions at 77 K in a frozen solution or in the solid state, attributable to metal-to-ligand charge transfers (MLCT). Variable-temperature 1H NMR experiments establish that complexes 1, 4, and 5 exist in isomeric forms in solution at ambient temperature due to the hindered rotation of the square PtC2N2 planes in the complexes.

Entities:  

Year:  2005        PMID: 15732973     DOI: 10.1021/ic0487530

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  7 in total

1.  Synthesis, characterization luminiscence studies and microbial activity of ethylenediamine ruthenium (II) complexes with dipyridophenazine ligands.

Authors:  Mynam Shilpa; Penumaka Nagababu; Y Praveen Kumar; J Naveena Lavanya Latha; M Rajender Reddy; K S Karthikeyan; Nazar Md Gabra; Sirasani Satyanarayana
Journal:  J Fluoresc       Date:  2010-12-22       Impact factor: 2.217

2.  Sensing metal ions with DNA building blocks: fluorescent pyridobenzimidazole nucleosides.

Authors:  Su Jeong Kim; Eric T Kool
Journal:  J Am Chem Soc       Date:  2006-05-10       Impact factor: 15.419

3.  2-(4-Fluoro-phen-yl)-1-phenyl-1H-imidazo[4,5-f][1,10]phenanthroline monohydrate.

Authors:  S Rosepriya; M Venkatesh Perumal; A Thiruvalluvar; J Jayabharathi; R J Butcher; J P Jasinski; J A Golen
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-07-09

4.  2-[(Quinolin-8-yl-oxy)meth-yl]-1H-benzimid-a-zole monohydrate.

Authors:  Lin Tang; Yue Zhang; Yonghong Wen
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-11-30

5.  Role of the Metal Center in the Modulation of the Aggregation Process of Amyloid Model Systems by Square Planar Complexes Bearing 2-(2'-pyridyl)benzimidazole Ligands.

Authors:  Daniele Florio; Ilaria Iacobucci; Giarita Ferraro; Ahmed M Mansour; Giancarlo Morelli; Maria Monti; Antonello Merlino; Daniela Marasco
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-12

6.  A novel coordination mode of κ1-N-Br-pyridylbenz-(imida, oxa or othia)-zole to Pt(ii): synthesis, characterization, electrochemical and structural analysis.

Authors:  Juan Nicasio-Collazo; Gonzalo Ramírez-García; Marcos Flores-Álamo; Silvia Gutiérrez-Granados; Juan M Peralta-Hernández; José Luis Maldonado; J Oscar C Jimenez-Halla; Oracio Serrano
Journal:  RSC Adv       Date:  2019-05-07       Impact factor: 4.036

7.  Synthesis, characterization, computational studies and biological activity evaluation of Cu, Fe, Co and Zn complexes with 2-butanone thiosemicarbazone and 1,10-phenanthroline ligands as anticancer and antibacterial agents.

Authors:  Tahmeena Khan; Iqbal Azad; Rumana Ahmad; Saman Raza; Shalini Dixit; Seema Joshi; Abdul Rahman Khan
Journal:  EXCLI J       Date:  2018-03-29       Impact factor: 4.068

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.